Skip to content

Prognosis Investigation and Intervention Study on Patients with novel coronavirus pneumonia (COVID-19) in recovery period Based on Community Health Management

Prognosis Investigation and Intervention Study on Patients with novel coronavirus pneumonia (COVID-19) in recovery period Based on Community Health Management

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030720
Enrollment
Unknown
Registered
2020-03-11
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Group 2:Western medicine conventional treatment
Group 1:TCM treatment

Sponsors

Hubei Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Conforming to the Chinese and Western Medicine Diagnostic Standards of patients with novel coronavirus pneumonia (COVID-19) in recovery period; 2. Aged between 18 and 65 years old; 3. Signing the generalized informed consent form (The intervention objects is incorporated in the clinical study as desired).

Exclusion criteria

Exclusion criteria: 1. Patients with severe primary diseases such as heart, kidney, lung, endocrine, blood, metabolism, and gastrointestinal tract, etc., may affect participation in the trial or may affect the outcome of the study by the judgment of the researcher; 2. Patients who have a family history of mental illness or have had a mental illness; 3. Patients who are allergic constitution or allergy to multiple drug; 4. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Medical imaging improvement rate in patients during recovery period;

Secondary

MeasureTime frame
traditional Chinese medical syndrome scale;TCM symptom integral;TCM Constitution;body temperature;Serum antibody;cellular immune factor;tongue demonstration;

Countries

China

Contacts

Public ContactXiaodong Li

Hubei Provincial Hospital of TCM

lixiaodong555@126.com+86 13908658127

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026